Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain.

Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain. Abstract Text:

Mauro Bianchi,Silvia Franchi,Paolo Ferrario,Maria Luisa Sotgiu,Paola Sacerdote,Mauro Bianchi,Silvia Franchi,Paolo Ferrario,Maria Luisa Sotgiu,Paola Sacerdote,

The anti-inflammatory and analgesic properties of different bisphosphonates have been demonstrated in both animal and human studies. Ibandronate is a third-generation bisphosphonate effective in managing different types of bone pain. In this study we investigated its effects in a standard pre-clinical model of inflammatory pain. We evaluated the effects of a single injection of different doses (0.5, 1.0, and 2.0mg/kg i.p.) of ibandronate on inflammatory oedema and cutaneous hyperalgesia produced by the intraplantar injection of complete Freund's adjuvant (CFA) in the rat hind-paw. In addition, we measured the effects of this drug (1.0mg/kg i.p.) on hind-paw levels of different pro-inflammatory mediators (PGE-2, SP, TNF-alpha, and IL-1beta). We also measured the levels of SP protein and of its mRNA in the ipsilateral dorsal root ganglia (DRG). Ibandronate proved able to reduce the inflammatory oedema, the hyperalgesia to mechanical stimulation, and the levels of SP in the inflamed tissue as measured 3 and 7 days following CFA-injection. This drug significantly reduced the levels of TNF-alpha and IL-1beta only on day 7. On the other hand, the levels of PGE-2 in the inflamed hind-paw were unaffected by the administration of this bisphosphonate. Finally, ibandronate blocked the overexpression of SP mRNA in DRG induced by CFA-injection in the hind-paw. These data help to complete the pharmacodynamic profile of ibandronate, while also suggesting an involvement of several inflammatory mediators, with special reference to substance P, in the analgesic action of this bisphosphonate.

Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain. Publishing Authors By Initials

M Bianchi,S Franchi,P Ferrario,ML Sotgiu,P Sacerdote,M Bianchi,S Franchi,P Ferrario,ML Sotgiu,P Sacerdote,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: European journal of pain (London, England)

VOLUME: 12

Page Numbers: 284-92

Journal Abbreviation:

ISSN: 1532-2149

DAY: 30

MONTH: 07

YEAR: 2007

Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9801774

Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain.

AFFILIATION: Department of Pharmacology, University of Milano, Via Vanvitelli 32, 20129 Milano, Italy.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Eur J Pain

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain Related Publications

• Effects of nimesulide on pain and on synovial fluid concentrations of substance P, interleukin-6 and interleukin-8 in patients with knee osteoarthritis: comparison with celecoxib.
• Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain.
• Immune cell-derived opioid peptides: back to the future.
• Novel endocrine disrupter effects of classic and atypical antipsychotic agents and divalproex: induction of adrenal hyperandrogenism, reversible with metformin or rosiglitazone.
• Opioid-induced immunosuppression.
• Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, met
• Plasma interleukin-1 beta concentrations in panic disorder.
• Sleep electroencephalographic patterns as a prognostic criteria in post-traumatic coma.
• The sleep cycle in coma: prognostic value.
• [Action of Hodgkin's disease blood on normal cells cultured in vitro.]
• [Not Available.]
• [Relation between alkaline phosphatase activity and fibrillogenesis in cortisone cultured cells.]
• [Repair of wounds in tissues cultivated in different media in vitro.]
• [The alkaline phosphatase activity of the normal and tumoral cell cultivated in vitro.]